INCY · Incyte Corp
$127.08
-2.85 (-2.19%)
At close · Jul 29
Market Cap
$25.96B
Shares
199.78M
Incyte Corp Earnings Call Transcripts
Every quarterly earnings call for Incyte Corp (INCY) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲1.3%
$823.30M
$112.78M
'22 Q3
22-11-01
·
$926.70M
$28.46M
'22 Q4
23-02-07
▲10.3%
$808.67M
$21.70M
'23 Q1
23-05-02
▲4.7%
$954.61M
$203.55M
'23 Q2
23-08-01
▲11.6%
$919.02M
$171.27M
'23 Q3
23-10-31
▲9.3%
$1.01B
$201.08M
'23 Q4
24-02-13
▲8.9%
$880.89M
$169.55M
'24 Q1
24-04-30
▲9.3%
$1.04B
−$444.60M
'24 Q2
24-07-30
▲23.8%
$1.14B
$106.46M
'24 Q3
24-10-29
▲16.3%
$1.18B
$201.21M
'24 Q4
25-02-10
▲19.5%
$1.05B
$158.20M
'25 Q1
25-04-29
▲16.5%
$1.22B
$405.00M
'25 Q2
25-07-29
▲20%
$1.37B
$424.17M
'25 Q3
25-10-28
▲27.8%
$1.51B
$299.28M
'25 Q4
26-02-10
LATEST
▲20.9%
$1.27B
$303.33M
'26 Q1
26-04-28
Earnings call
FY26 · Q2
2026-07-28
Incyte Corp Q2 FY2026 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-09
Goldman Sachs Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-08
Incyte Conference Call
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-04-28
Incyte Corp Q1 FY2026 Earnings Call
Confident tone
Geographic and international growth
Core business expansion beyond Jakify
Pipeline and regulatory milestones
Revenue
$1.27B
▲ 20.9% YoY Diluted EPS
$1.47
▲ 83.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-11
Barclays 28th Annual Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-10
Incyte Corp Q4 FY2025 Earnings Call
Confident tone
2025 Financial Performance and 2026 Outlook
Pipeline Risks and Clinical Readouts
Jakafi Franchise and Jakafi XR
Revenue
$1.51B*
▲ 27.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-28
Incyte Corp Q3 FY2025 Earnings Call
Confident tone
Hem/onc innovation focus (MPNs, 989, 617)
Niktimvo launch trajectory
Jakafi performance and guidance raise
Revenue
$1.37B
▲ 20% YoY Diluted EPS
$2.11
▲ 290.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-29
Incyte Corp Q2 FY2025 Earnings Call
Confident tone
Pipeline catalysts (989, povorcitinib, axatilimab)
Jakafi demand outlook and IRA
Niktimvo launch
Revenue
$1.22B
▲ 16.5% YoY Diluted EPS
$2.04
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-29
Incyte Corp Q1 FY2025 Earnings Call
Confident tone
Jakafi commercial performance and guidance raise
Financial results and operating expenses
KRAS G12D inhibitor competitive landscape
Revenue
$1.05B
▲ 19.5% YoY Diluted EPS
$0.80
▲ 6.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-10
Incyte Corp Q4 FY2024 Earnings Call
Confident tone
Jakafi (ruxolitinib) performance and guidance
Opzelura growth and pediatric atopic dermatitis launch
2025 pipeline catalysts and pivotal readouts
Revenue
$1.18B*
▲ 16.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-29
Incyte Corp Q3 FY2024 Earnings Call
Confident tone
Opzelura growth and geographic expansion
Jakafi commercial performance and guidance raise
CDK2 inhibitor competitive positioning
Revenue
$1.14B
▲ 23.8% YoY Diluted EPS
$0.54
▼ 28.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-30
Incyte Corp Q2 FY2024 Earnings Call
Confident tone
Opzelura growth and expansion
Jakafi commercial performance and guidance
Pipeline transformation and prioritization
Revenue
$1.04B
▲ 9.3% YoY Diluted EPS
$-2.04
▼ 326.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-30
Incyte Corp Q1 FY2024 Earnings Call
Positive tone
Jakafi performance
Opzelura growth
Pipeline launches by 2030
Revenue
$880.89M
▲ 8.9% YoY Diluted EPS
$0.75
▲ 650% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-13
Incyte Corp Q4 FY2023 Earnings Call
Confident tone
Opzelura launch momentum
Jakafi commercial performance and 2024 guidance
Pipeline and ten high-impact launches by 2030
Revenue
$1.01B*
▲ 9.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-31
Incyte Corp Q3 FY2023 Earnings Call
Revenue
$919.02M
▲ 11.6% YoY Diluted EPS
$0.76
▲ 52% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-01
Incyte Corp Q2 FY2023 Earnings Call
Revenue
$954.61M
▲ 4.7% YoY Diluted EPS
$0.90
▲ 25% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-02
Incyte Corp Q1 FY2023 Earnings Call
Revenue
$808.67M
▲ 10.3% YoY Diluted EPS
$0.10
▼ 41.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-07
Incyte Corp Q4 FY2022 Earnings Call
Revenue
$926.70M*
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-01
Incyte Corp Q3 FY2022 Earnings Call
Revenue
$823.30M
▲ 1.3% YoY Diluted EPS
$0.50
▼ 39% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
Incyte Corp Q2 FY2022 Earnings Call
Revenue
$911.40M
Diluted EPS
$0.72
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-03
Incyte Corp Q1 FY2022 Earnings Call
Revenue
$733.24M
▲ 21.3% YoY Diluted EPS
$0.17
▼ 29.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-08
Incyte Corp Q4 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-02
Incyte Corp Q3 FY2021 Earnings Call
Revenue
$812.99M
Diluted EPS
$0.82
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-03
Incyte Corp Q2 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Incyte Corp Q1 FY2021 Earnings Call
Revenue
$604.72M
▲ 6.4% YoY Diluted EPS
$0.24
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-09
Incyte Corp Q4 FY2020 Earnings Call
Revenue
$789.51M
▲ 36.3% YoY Diluted EPS
$0.68
▲ 33.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Incyte Corp Q3 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-04
Incyte Corp Q2 FY2020 Earnings Call
Revenue
$705.71M
▲ 33.2% YoY Diluted EPS
$0.67
▲ 39.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-05
Incyte Corp Q1 FY2020 Earnings Call
Revenue
$568.51M
▲ 14.2% YoY Diluted EPS
$-3.33
▼ 808.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-13
Incyte Corp Q4 FY2019 Earnings Call
Revenue
$579.39M
▲ 9.6% YoY Diluted EPS
$0.51
▲ 59.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–30 of 30 earnings calls